Strain-specific galactose utilization by commensal E. coli mitigates Salmonella establishment in the gut
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013232 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Christopher Schubert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Institute of Microbiology, ETH Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Escherichia coli, Gastrointestinal Microbiome, Galactose, Salmonella typhimurium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, National Centre of Competence in Research (NCCR), German Research Foundation.
Abstract (Originalsprache)
Salmonella enterica serovar Typhimurium ( S . Tm) is a major cause of gastrointestinal diseases worldwide. To date, options for prevention or curative therapy remain limited. The gut microbiota plays a protective role against enteric diseases, particularly in preventing establishment and proliferation of S . Tm. While most research has focused on microbiota-mediated pathogen exclusion during the later, inflammation-dominated stages of infection, little is known about how microbiota members mitigate S . Tm early gut colonization. To address this gap, we conducted 24 h in vivo competitive experiments using S . Tm and different commensal E. coli strains. We observed a significant reduction in pathogen load, which was strain-specific and particularly evident with E. coli 8178. To investigate the underlying molecular mechanisms, we performed an in vivo screen using a rationally designed S . Tm library—which includes a wide range of carbohydrate utilization mutants—both in the absence and presence of E. coli strains. Our findings revealed that E. coli 8178-mediated S . Tm competition was driven by the exploitation of galactose during the early stage of infection. Identifying galactose as a key metabolite in pathogen exclusion by gut microbiota members enhances our mechanistic understanding of microbiota-mediated protection and opens new avenues for developing microbiota- and dietary-based strategies to better control intestinal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
- Department of Microbiology and Immunology, Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, SingaporeSingapore.
ORCID-Profile: Wolf-Dietrich Hardt
Förderung
- Swiss National Science Foundation
- National Centre of Competence in Research (NCCR)
- German Research Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- NCCR Microbiomes
- European Molecular Biology Organization
Zitieren
APA
Schubert, C., Näf, J., Petukhov, L., Laganenka, L., Cherrak, Y., & Hardt, W. D. (2025). Strain-specific galactose utilization by commensal E. coli mitigates Salmonella establishment in the gut. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013232
Vancouver
Schubert C, Näf J, Petukhov L, Laganenka L, Cherrak Y, Hardt WD. Strain-specific galactose utilization by commensal E. coli mitigates Salmonella establishment in the gut. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013232
BibTeX
@article{Schubert2025,
author = {Schubert, Christopher and Näf, Jana and Petukhov, Lisa and Laganenka, Leanid and Cherrak, Yassine and Hardt, Wolf-Dietrich},
title = {Strain-specific galactose utilization by commensal E. coli mitigates Salmonella establishment in the gut},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013232}
}
EUVIMED